Sunovion Pharmaceuticals Inc. Names Mark Iwicki as CEO

August 24, 2011

MARLBOUGH,Mass., August 24, 2011 – Sunovion Pharmaceuticals Inc. recently announced that Mark Iwicki, formerly Sunovion’s President and Chief Operating Officer, was named as the company’s new President and Chief Executive Officer effective June 24, 2011. Mr. Iwicki joined Sunovion's predecessor, Sepracor, in October 2007 as Executive Vice President and Chief Commercial Officer. During his tenure as CCO he helped the company launch two respiratory products and implemented a successful new commercial model. In 2010, he became President and Chief Operating Officer and a member of Sepracor's Board of Directors. He was responsible for shepherding Sepracor through its successful acquisition by Dainippon Sumitomo Pharma Co., Ltd. Sepracor changed its name to Sunovion Pharmaceuticals Inc. in October of 2010. Mr. Iwicki has over 20 years experience in the pharmaceutical industry, including leadership roles at Novartis, Merck and Astra Merck Inc. He currently serves as a board member of The Pharmaceutical Research and Manufacturers of America (PhRMA). Mr. Saburo Hamanaka, Sunovion’s former Chairman and Chief Executive Officer will remain at Sunovion in a new role as Executive Vice President of Corporate Strategy, overseeing the company’s new product planning and corporate development and licensing activities.

Sunovion has seven marketed products in theUnited Statesand most recently launched LATUDA® (lurasidone HCI), for the treatment of schizophrenia in adults. Sunovion has approximately 2,500 employees in theU.S., including 700 inMassachusettsat its corporate headquarters inMarlborough,Mass.

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.